top of page
.png)
Eyes on Pharma
Check-out What Intel Caught our Eye
Corporate Strategy Updates -BioNTech, Pfizer, and Astra Zeneca+BMS
We've been keeping EyesOn Strategic moves in the BioPharma space. Today we look at BioNTech's new CEO, Pfizer's continuing restructuring moves to remain competitive, and the reactions to a potential BMS + AZN merger.
Jana Chisholm
Aug 286 min read
Operational Pressure Builds: Layoffs, Supply Risk, and Regulatory Friction
From workforce reductions to manufacturing bottlenecks and regulatory divergence, structural pressures are reshaping how pharma operates.
Jana Chisholm
Apr 204 min read
bottom of page